Risk of ovarian cancer in women with symptoms in primary care: population based case-control study.
OBJECTIVE
To identify and quantify symptoms of ovarian cancer in women in primary care.


METHODS
Case-control study, with coding of participants' primary care records for one year before diagnosis.


METHODS
39 general practices in Devon, England.


METHODS
212 women aged over 40 with a diagnosis of primary ovarian cancer, 2000-7; 1060 controls matched by age and general practice.


METHODS
Odds ratios and positive predictive values for symptoms from conditional logistic regression analyses.


RESULTS
Seven symptoms were associated with ovarian cancer in multivariable analysis. The univariable positive predictive values and multivariable odds ratios (with 95% confidence intervals) for these were 2.5% (1.2% to 5.9%) and 240 (46 to 1200) for abdominal distension; 0.5% (0.2% to 0.9%) and 24 (9.3 to 64) for postmenopausal bleeding; 0.6% (0.3% to 1.0%) and 17 (6.1 to 50) for loss of appetite; 0.2% (0.1% to 0.3%) and 16 (5.6 to 48) for increased urinary frequency; 0.3% (0.2% to 0.3%) and 12 (6.1 to 22) for abdominal pain; 0.2% (0.1% to 0.4%) and 7.6 (2.5 to 23) for rectal bleeding; and 0.3% (0.2% to 0.6%) and 5.3 (1.8 to 16) for abdominal bloating. In 181 (85%) cases and 164 (15%) controls at least one of these seven symptoms was reported to primary care before diagnosis. After exclusion of symptoms reported in the 180 days before diagnosis, abdominal distension, urinary frequency, and abdominal pain remained independently associated with a diagnosis of ovarian cancer.


CONCLUSIONS
Women with ovarian cancer usually have symptoms and report them to primary care, sometimes months before diagnosis. This study provides an evidence base for selection of patients for investigation, both for clinicians and for developers of guidelines.
Hamilton
William
W
NIHR School for Primary Care Research, Department of Community Based Medicine, University of Bristol, Bristol BS8 2AA, UK. w.hamilton@bristol.ac.uk
Peters
Tim J
TJ
Bankhead
Clare
C
Sharp
Deborah
D
D015746:Abdominal Pain / Q000209:etiology; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D042241:Early Diagnosis; D004812:Epidemiologic Methods; D005194:Family Practice; D001068:Feeding and Eating Disorders / Q000209:etiology; D005260:Female; D005767:Gastrointestinal Diseases / Q000209:etiology; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000150:complications / Q000175:diagnosis*; D014555:Urination Disorders / Q000209:etiology
Gynecol Oncol. 2003 Jul;90(1):75-82
12821345
Thorax. 2005 Dec;60(12):1059-65
16227326
Lancet Oncol. 2009 Apr;10(4):327-40
19282241
Gynecol Oncol. 2004 Jan;92(1):232-9
14751164
Cancer. 2005 Oct 1;104(7):1398-407
16116591
Clin Cancer Res. 2008 Sep 15;14(18):5833-9
18794094
Aust N Z J Obstet Gynaecol. 2005 Jun;45(3):211-4
15904446
J Pain Symptom Manage. 2003 Jun;25(6):528-38
12782433
BJOG. 2007 Jan;114(1):59-64
17233861
Eur J Gynaecol Oncol. 2007;28(5):376-80
17966216
Obstet Gynecol. 2007 May;109(5):1053-61
17470582
BJOG. 2005 Jul;112(7):857-65
15957984
BJOG. 2008 Jul;115(8):1008-14
18651882
Gynecol Oncol. 2001 Dec;83(3):466-71
11733956
Gynecol Oncol. 2003 Sep;90(3):651-6
13678740
Obstet Gynecol. 2001 Aug;98(2):212-7
11506835
JAMA. 2004 Jun 9;291(22):2705-12
15187051
Fam Pract. 2005 Oct;22(5):548-53
15964871
Br J Cancer. 2005 Aug 22;93(4):399-405
16106247
Lancet Oncol. 2007 Sep;8(9):773-83
17714991
Int J Epidemiol. 2005 Apr;34(2):353-67
15659468
Cancer. 2000 Nov 15;89(10):2068-75
11066047
Crit Rev Oncol Hematol. 2006 Nov;60(2):159-79
17018256